1 discussed xenoestrogens (environmental pollutants) and possible human health impact through breast-feeding exposure. Two important aspects escaped this scholarly discussion of environmental pollution and breastfeeding contamination: (a) estrogenicity of other substances in the maternal diet, and (b) the placenta (and fat metabolism) as an additional source of vertical transmission of endocrine disruptors.
Xenoestrogens are broadly used to describe substances having estrogen-like activity; however, this categorization includes natural plant components as well as toxic pollutants with diverse chemical profile and distinct metabolism. Phytoestrogens are natural primary obligatory constituents of plants, which are easily metabolized after consumption. Unlike toxic pollutants, phytoestrogens are rapidly metabolized and do not bioaccumulate in the food chain; their half life is about 6-8 h. 2 The human diet contains multiple phytochemicals that exhibit both estrogen and antiestrogenic activities, and dietary levels of these compounds are of orders of magnitude higher than ''xenoestrogen'' (environmental pollutants) contaminants. 3 Furthermore, phytoestrogens are an inherent part of soy-based infant formulas. Xenoestrogens referred to by Massart et al. were exclusively environmental halogenated-pollutants. Contrary to phytoestrogens, man-made organohalogenated substances (mostly chlorinated; organochlorides >organobromides) are persistent in the environment and accumulate in long-living humans. However, besides estrogenic activity, these contaminants also have antiestrogenic, antiandrogenic and androgenic actions. Since these pollutants occur as mixtures, it is not yet possible to know if their effects are additive or antagonistic. Therefore, here they are also referred to as endocrine active pollutants (EAP).
Factoring infant exposure through breast milk is only one aspect of a complex mosaic of maternal contamination that affects fetal and infant exposure as well as their susceptibility to endocrine-disruptive effects. Studies relating the offspring's endocrine insults (in uterus and ex uterus) to maternal EAP body-stores are complicated to conduct because of the difficulty of disentangling the single effect from the cumulative effects of EAP mixtures. Furthermore, human prenatal toxic insults may appear after breast-feeding age. However, it is important to notice that specific estrogens (ethinyl estradiol) that entered breast milk as a result of maternal contraceptive treatment were never demonstrated. Therefore, maternal EAP found in breast milk are an indicator of infant contamination that includes a much earlier and more vulnerable time F fetal development.
Lipophilic EAP are not eliminated in urine, have a slow turnover and a long estimated half-life of 3.7 to 7 years. As a result of that, lipid metabolism is thought to be the governing mechanism controlling storage and circulating levels of EAP. Thus, increased lipolysis and lipogenesis during pregnancy and lactation also increases availability of EAP for fetuses and nursing infants. Because of the fetuses' limited buffering due to their small fat compartment, high levels of maternal EAP (mobilized and dietary) perfuse the fetus and, without retention, return to the mother. Thus, the human fetus is exposed to lipophilic xenobiotics from lipid-rich placenta, which concentrates these substances. On a lipid basis, fat-rich placenta retains a proportionally higher concentration of EAP than fetal subcutaneous fat. Indeed, EAP are higher in placenta than in breast milk. 4 Likewise, phytoestrogens are transferred from mother to fetus and tend to stay longer in the fetus. 5 Fetal fat metabolism changes rapidly in the postnatal period, and differences in fat metabolism and adiposity between preand post-partum determine the pattern of EAP accumulation. Infant exposure to pollutants during breast-feeding is buffered by a fast increase in adipose tissue relative to intrauterine life. The fetus starts accumulating fat after 26 weeks gestation, reaching 1/3 of total body weight at the time of birth. Between the 40th and 42nd week of gestation, however, there is a distinct fall in fetal fat deposition. Also, the proportion of fetal lipids in the adipose-tissue compartment is only 45% in the last trimester of pregnancy compared to 4 months of age. This proportion increases to adult levels by 1 year of age. 6 This peculiarity in fat metabolism during early life favors the accumulation of lipophilic substances in the expanding ''lipid compartment,'' partly explaining the high body burden of EAP in breast-fed infants. Postnatal EAP absorbed from breast milk can be stored in the increasing and differentiating adipose tissue structures not available during fetal exposure.
Hormone-mimetic activities of pollutants in developmental toxicology depend on timing and dosing. Halogenated pollutants in maternal fat are the main determinants of antenatal (fetal) and postnatal release (breast-feeding) and vertical contamination of infants. Acquisition of, or exposure to, EAP is modulated by constitutional variables related to fat metabolism (of both mother and offspring) during a reproductive cycle (gestation and lactation). Although there is no critical maternal-residue level linking EAP to infant health issues, during pregnancy the dosing (continuous maternal supply of EAP) is higher and the timing (fetal development) is more aggravating to the infant's health than during breast-feeding. Coupled with that, the increase in postpartum fat accumulation endows breast-fed infants with a buffering compartment that retains EAP, possibly attenuating its effects. This may explain that the children who were breast-fed had higher EAP levels than children who were exposed only in uterus, but consistently performed better than those who were formula fed.
